HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells

被引:0
|
作者
Seebach, JD
Comrack, C
Germana, S
LeGuern, C
Sachs, DH
DerSimonian, H
机构
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is increasing evidence that NK cells make an important contribution to human anti-porcine xenogeneic cytotoxicity. Most allogeneic as well as autologous normal cells are not susceptible to NK cell-mediated cytotoxicity because they express inhibitory molecules encoded within the MHC class I loci. The protective signal is delivered to NK cells through killer cell-inhibitory receptors expressing different MHC class I specificities, It has been proposed that xenogeneic target cells may be susceptible to NK cell-mediated lysis because their MHC class I molecules fail to be recognized by human killer cell-inhibitory receptors, To explore this hypothesis, we examined the effect of human MHC class I expression on porcine target cell lysis by human NK cells, An immortalized porcine bone marrow-derived endothelial cell line (2A2) was transfected with three different human MHC class I allelic genes (HLA-A2, -B27, or -Cw3), The cytotoxic activity of several CL183(+) NK clones, which lysed untransfected porcine cells effectively, was substantially blocked by the presence of HLA-Cw3. In contrast, HLA-Cw3-positive cells were not protected against lysis by CL183(-)EB6(+) NK clones, The expression of HLA-B27 or HLA-A2 molecules on pig target cells did not provide substantial protection from lysis by any of the NK clones tested, In addition to confirming the hypothetical basis of NK cell-mediated killing of xenogeneic targets, these results have practical implications as an approach to overcoming NK cell-mediated cytotoxicity, which may be an obstacle to pig-to-human xenotransplantation.
引用
收藏
页码:3655 / 3661
页数:7
相关论文
共 50 条
  • [21] HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells
    Forte, P
    Pazmany, L
    Matter-Reissmann, UB
    Stussi, G
    Schneider, MKJ
    Seebach, JD
    JOURNAL OF IMMUNOLOGY, 2001, 167 (10): : 6002 - 6008
  • [23] HLA-G inhibits xenogenetic cytotoxicity mediated by human NK cells and T lymphocytes against PECs
    Shi, B
    Yin, HJ
    Huang, XY
    Sun, FZ
    CHINESE SCIENCE BULLETIN, 2003, 48 (02): : 148 - 153
  • [24] A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity
    Zeng, M. H.
    Fang, C. Y.
    Wang, S. S.
    Zhu, M.
    Xie, L.
    Li, R.
    Wang, L.
    Wu, X. W.
    Chen, S.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3312 - 3314
  • [25] Co-expression of HLA-E and HLA-G in Porcine Endothelial Cells Attenuates Human Natural Killer Cell-Mediated Cytotoxicity
    Cross-Najafi, Arthur
    Lopez, Kevin
    Park, Yujin
    Isidan, Kadir
    Zhang, Wenjun
    Li, Ping
    Ekser, Burcin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S267 - S267
  • [26] Human NK cytotoxicity against porcine endothelial cells is triggered by NKp44 and NKG2D
    Lilienfeld, BG
    Forte, P
    Baumann, BC
    Seebach, JD
    XENOTRANSPLANTATION, 2005, 12 (05) : 396 - 396
  • [27] Zinc protects human endothelial vascular cells against the glucose induced cytotoxicity
    Lalanne, K
    Bouvard, S
    Wiernsperger, N
    Faure, P
    Favier, A
    Halimi, S
    TRACE ELEMENTS IN MAN AND ANIMALS 10, 2000, : 140 - 140
  • [28] HLA-G1 protects JEG-3 choriocarcinoma cells against NK cells
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 500 - 501
  • [29] HLA-G1 protects Jeg-3 choriocarcinoma cells against NK cells
    Poehlmann, TG
    Winzer, H
    Wengenmayer, T
    Busch, S
    Markert, UR
    PLACENTA, 2005, 26 (8-9) : A28 - A28
  • [30] HLA-E and HLA-G Co-expression in Porcine Endothelial Cells Attenuate Human NK Cell Degranulation
    Farag, Kristine
    Cross-Najafi, Arthur
    Wilmes, Danielle
    Zhang, Wenjun
    Li, Ping
    Ekser, Burcin
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (01) : S18 - S19